The main pre-registration reports evaluating the efficacy and safety of OCA are documented in Desk 1. Ocular: Interrupt therapy for suspected keratitis; take into account discontinuation if analysis of ulcerative keratitis is verified. Completely discontinue for persistent ulcerative keratitis. - Are actively suicidal (eg, any suicide attempts in the previous https://jacquesk555fyp6.activoblog.com/profile